Item 1(a). | Name of Issuer: |
Fractyl Health, Inc.
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
3 Van de Graaff Drive Suite 200
Burlington, Massachusetts 01803
Item 2(a). | Names of Persons Filing: |
This Schedule 13G (the “Schedule 13G”) is being filed on behalf of each of the following persons (each, a “Reporting Person”):
(i) Maverick Capital, Ltd.;
(ii) Maverick Capital Management, LLC; and
(iii) Lee S. Ainslie III (“Mr. Ainslie”).
The Schedule 13G relates to the shares of Common Stock (as defined herein) held for the accounts of Maverick Capital, Ltd.’s clients.
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The address of the principal business office of (i) Maverick Capital, Ltd. and Maverick Capital Management, LLC is 1900 N. Pearl Street, 20th Floor, Dallas, Texas 75201, and (ii) Mr. Ainslie is 360 South Rosemary Ave., Suite 1440, West Palm Beach, Florida 33401.
(i) Maverick Capital, Ltd. is a Texas limited partnership;
(ii) Maverick Capital Management, LLC is a Texas limited liability company; and
(iii) Mr. Ainslie is a citizen of the United States.
Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.00001 per share (“Common Stock”)
35168W103